hIL1RL1/hIL4/hIL4R
品系全名
C57BL/6Smoc-Il1rl1tm4(hIL1RL1)Il4tm3(hIL4)Il4ratm1(hIL4R)Smoc
目錄號(hào)
NM-HU-232112
品系狀態(tài)
胚胎凍存
品系描述
驗(yàn)證數(shù)據(jù)
Fig1. Expression of hIL1RL1 on CD4+ T cells in spleen in hIL1RL1/hIL4/hIL4R tKI mice.
Fig2. Expression of hIL1RL1 on mast cells in bone marrow in hIL1RL1/hIL4/hIL4R tKI mice.
Fig3. Detection of soluble form hIL4RA (A) and mIL4RA (B) expression in hIL4RA mice by ELISA.?
Abbr. HO: homozygote; WT: Wild type; ND: Not detected.
Fig4. Analysis of hIL4R expression in the spleen in hIL4/hIL4R dKI mice by FACS.?
Fig5. Evaluation of an Anti-huIL4Ra mAb in the OXA-Induced Atopic Dermatitis Model in hIL4/hIL4Ra dKI Mice.?
Both dupilumab and Dexamethasone ameliorate overall atopic dermatitis activity in OXA - challenged ears, but only Dexamethasone worked in back skin. (In cooperation with CrownBio)
Fig6. Dupilumab significantly mitigates inflammatory cell infiltration in lesioned ear. (In cooperation with CrownBio)?
Note: Inflammatory cell infiltration is indicated by black arrows, 10X images
Fig7. Low dose dupilumab significantly mitigates inflammatory cell infiltration in lesioned skin.??(In cooperation with CrownBio)?
Note: Inflammatory cell infiltration is indicated by black arrows, 10X images
Fig8. Dexamethasone and dupilumab treatments are well tolerated. Both significantly reduced IgE levels in serum but not spleen weight.?(In cooperation with CrownBio)?
Ordinary one-way ANOVA were applied for analysis compared to Isotype group, *p<0.05, **p<0.01, *** p<0.001.
Fig9. Repeated OXA-induced Th2 cytokine production (hIL-4 elevation) and dupilumab treatment significantly reduces IL-6 and KC/GRO levels in lesioned ear.?(In cooperation with CrownBio)?
Ordinary one-way ANOVA were applied for analysis compared to Isotype group, *p<0.05, **p<0.01, *** p<0.001.
Fig10. Repeated OXA-induced Th2 cytokine production (hIL-4 elevation) and dupilumab treatment significantly reduces IL-5 and IL-2 levels in lesioned skin.?(In cooperation with CrownBio)?
Ordinary one-way ANOVA were applied for analysis compared to Isotype group, *p<0.05, **p<0.01, *** p<0.001.
你也可能感興趣
Cre-ERT2在無(wú)Tamoxifen誘導(dǎo)的情況下,在細(xì)胞質(zhì)內(nèi)處于無(wú)活性狀態(tài);當(dāng)Tamoxifen誘導(dǎo)后,Tamoxifen的代謝產(chǎn)物4-OHT(雌激素類(lèi)似物)與ERT結(jié)合,可使Cre-ERT2進(jìn)核發(fā)揮Cre重組酶活性。
查看常見(jiàn)的基因工程小鼠可以分為兩種命名方式,包括基因定點(diǎn)修飾的小鼠命名,比如:敲除、敲入、點(diǎn)突變等等,和隨機(jī)轉(zhuǎn)基因的小鼠命名。
查看